• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Anixa Biosciences Inc (NQ: ANIX )

    3.150 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 3.150
    Bid (Size) 3.040 (2)
    Ask (Size) 3.300 (1)
    Prev. Close 3.150
    Today's Range 3.150 - 3.150
    52wk Range 2.145 - 5.130
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Anixa Biosciences And 3 Other Stocks Under $5 Insiders Are Buying
    Via Benzinga
    EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy
    FDA Approves Anixa Biosciences' Ovarian Cancer CAR-T Therapy for Individual Patient Trial. Moffit Cancer Center receives approval for a second dose in an ongoing Phase I trial showing early promising... 
    Via Benzinga
    Exposures Product Safety

    Performance

    YTD
    -19.85%
    -19.85%
    1 Month
    -2.48%
    -2.48%
    3 Month
    +38.77%
    +38.77%
    6 Month
    -1.56%
    -1.56%
    1 Year
    +4.30%
    +4.30%

    More News

    Read More
    EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued, Launches $5M Stock Buyback Program
    Via Benzinga
    ANIX Stock Earnings: Anixa Biosciences Beats EPS for Q2 2024
    Via InvestorPlace
    7 Penny Biotech Stocks to Triple Your Investment
    Via InvestorPlace
    Recap: Anixa Biosciences Q1 Earnings
    Via Benzinga
    6 Analysts Have This to Say About Anixa Biosciences
    Via Benzinga
    The Latest Analyst Ratings for Anixa Biosciences
    Via Benzinga
    Expert Ratings for Anixa Biosciences
    Via Benzinga
    Anixa Biosciences, Inc. (NASDAQ: ANIX) Featured in Coverage of the EF Hutton Annual Global Conference
    Via Investor Brand Network
    Sidoti Events, LLC's Virtual May Micro-Cap Conference
    Via ACCESSWIRE
    Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
    Via AB Newswire
    Sidoti Events, LLC's Virtual January Micro-Cap Conference
    Via ACCESSWIRE
    Anixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape?
    Via Benzinga
    3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023
    Via InvestorPlace
    Anixa Biosciences Reveals Updated Data From Breast Cancer Vaccine Trial, Says 'Exceeded Expectations'
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    The 3 Most Undervalued Cheap Stocks to Buy in September 2023
    Via InvestorPlace
    Could Anixa Biosciences (NASDAQ:ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
    Via ACCESSWIRE
    Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
    Via Benzinga
    Anixa Biosciences And 2 Other Penny Stocks Insiders Are Aggressively Buying
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Appreciating The Passing Of A Titan & Incorporating Alternative Data Signals
    Via Talk Markets
    Benzinga's Top Ratings Upgrades, Downgrades For December 23, 2022
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.